CD274 and urinary bladder cancer: In the bladder cancer cohort subjected to PD-L1 blockade, patients with a higher baseline COX-IS similarly had a worse outcome (Figures 7F and S7C), with the top group showing a median survival of only 6 months compared to more than 1.5 years in the bottom quarter.